Viking Therapeutics
Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.
VKTX Key Statistics
Stock Snapshot
As of today, Viking Therapeutics(VKTX) shares are valued at $33.50. The company's market cap stands at 3.91B, with a P/E ratio of -10.63.
During the trading session on 2026-03-01, Viking Therapeutics(VKTX) shares reached a daily high of $33.95 and a low of $32.00. At a current price of $33.50, the stock is +4.7% higher than the low and still -1.3% under the high.
Trading activity shows a volume of 2.04M, compared to an average daily volume of 2.59M.
The stock's 52-week range extends from a low of $18.92 to a high of $43.15.
The stock's 52-week range extends from a low of $18.92 to a high of $43.15.
VKTX News
Viking Therapeutics has completed enrollment in its Phase 3 VANQUISH-1 trial of VK2735, a dual GLP-1 and GIP receptor agonist for obesity. The company is advan...
Key Points Viking Therapeutics' leading candidate posted strong mid-stage data and is undergoing phase 3 studies. Though there are some risks, the stock could...
Analyst ratings
94%
of 18 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.